Search For "novel drug development programme"
Fitch affirms Glenmark Pharmaceuticals at BB, withdraws proposed bond rati
Updated : 5 years, 8 months ago IST
Singapore, July 10 (ANI): Fitch Ratings has affirmed Glenmark Pharmaceuticals' long-term issuer default rating at BB with a stable outlook.
Read More